 | Processa Pharmaceuticals, Inc. | |||
| NCM : PCSA || Location: United States | ||||
$1.62+0.02 (+1.25%) |
0.04 M | 1.56 - 1.68 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.036 M |
| March 15, 2024 | 0.040 M |
| Feb. 29, 2024 | 0.067 M |
| Feb. 15, 2024 | 0.096 M |
| Jan. 31, 2024 | 0.162 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -1.63 | -1.70 | -4.17% |
| 09/30/2023 | -2.04 | -1.60 | 21.57% |
| 03/31/2023 | -5.71 | -3.60 | 36.97% |
| 12/31/2022 | -6.53 | -7.20 | -10.29% |
| 09/30/2022 | -0.34 | -0.37 | -7.75% |
PCSA Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 2.856M | Shares Float | 2.491M |
| Short Float | 0.036M | Market Cap | 4.63M |
| Institution ownership | 1.96% | Insider ownership | 11.271% |
| Earnings Date | 05/13/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -8.48 | Forward EPS | -6.00 |